Condition (MeSH)
Carcinoma, Mucoepidermoid
ClinicalTrials.gov lists 4 trials for Carcinoma, Mucoepidermoid or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
4 of the 4 trials are tagged with Carcinoma, Mucoepidermoid itself; the rest are tagged with a narrower condition beneath it.
When did Carcinoma, Mucoepidermoid trials start? (4)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 1/2
- Not applicable
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2020 | 1 |
| 2019 | 1 |
| 2018 | 1 |
| 2011 | 1 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 4 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Carcinoma, Mucoepidermoid trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 1/2 | 1 |
| Not applicable | 2 |
How many Carcinoma, Mucoepidermoid trials are recruiting? (3)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Completed | 2 |
| Terminated | 1 |
| Unknown status | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Carcinoma, Mucoepidermoid trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Klus Pharma Inc. | 1 |
| Poseida Therapeutics, Inc. | 1 |
Which publications cover Carcinoma, Mucoepidermoid? (7)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Clinicopathologic and genetic features of primary bronchopulmonary mucoepidermoid carcinoma: the MD Anderson Cancer Center experience and comprehensive review of the literature. | Virchows Archiv : an international journal of pathology | 2017 | Yes |
| Low-grade bronchial mucoepidermoid carcinoma during pregnancy successfully treated by lobectomy. | Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology | 2017 | Yes |
| Hypothyroidism in patients treated with radiotherapy for head and neck carcinoma: standardised long-term follow-up study. | The Journal of laryngology and otology | 2016 | Yes |
| Salivary gland carcinoma in Denmark 1990-2005: a national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA). | Oral oncology | 2011 | Yes |
| Robotic-assisted surgery for primary or recurrent oropharyngeal carcinoma. | Archives of otolaryngology--head & neck surgery | 2010 | Yes |
Showing 5 of 7 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.